Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential

Annoura, 1996, A novel class of antagonist for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropachromen-1a-carboxylates, Bioorg Med Chem Lett, 6, 763, 10.1016/0960-894X(96)00104-7 Anwyl, 1999, Metabotropic glutamate receptors: electrophysiological properties and role in plasticity, Brain Res Rev, 29, 83, 10.1016/S0165-0173(98)00050-2 Bhave, 2001, Peripheral group I metabotropic glutamate receptors modulate nociception in mice, Nat Neurosci, 4, 417, 10.1038/86075 Bhave, 2003, Membrane topology of a metabotropic glutamate receptor, J Biol Chem, 278, 30294, 10.1074/jbc.M303258200 Brabet, 1995, Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses, Neuropharmacology, 34, 895, 10.1016/0028-3908(95)00079-L Carroll, 2001, BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity, Mol Pharmacol, 59, 965, 10.1124/mol.59.5.965 Cartmell, 2000, Regulation of neurotransmitter release by metabotropic glutamate receptors, J Neurochem, 75, 889, 10.1046/j.1471-4159.2000.0750889.x Chavez-Noriega, 2002, Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia, Curr Drug Target CNS Neurol Disord, 1, 261, 10.2174/1568007023339337 Chiamulera, 2001, Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice, Nat Neurosci, 4, 873, 10.1038/nn0901-873 Conigrave, 2000, l-Amino acid sensing by the extracellular Ca2+-sensing receptor, Proc Natl Acad Sci U S A, 97, 4814, 10.1073/pnas.97.9.4814 Cosford, 2003, [3H]-Methoxymethyl-MTEP and [3H]-Methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor, Bioorg Med Chem Lett, 13, 351, 10.1016/S0960-894X(02)00997-6 Cosford, 2003, 3-[2-Methyl-1,3-thiazol-4yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity, J Med Chem, 46, 204, 10.1021/jm025570j Doherty, 2002, The roles of metabotropic glutamate receptors in seizure and epilepsy, Curr Drug Target CNS Neurol Disord, 1, 251, 10.2174/1568007023339355 Dunham, 1999, Conformational changes in rhodopsin, J Biol Chem, 274, 1683, 10.1074/jbc.274.3.1683 Farrens, 1996, Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin, Science, 274, 768, 10.1126/science.274.5288.768 Flor, 2002, Neuroprotective activity of metabotropic glutamate receptor ligands, Adv Exp Med Biol, 513, 197, 10.1007/978-1-4615-0123-7_7 Gasparini, 1999, 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist, Neuropharmacology, 38, 1493, 10.1016/S0028-3908(99)00082-9 Gatti, 2001, 8-Arylethynyl-1,3-dihrdro-benzo[b][1,4]diazepin-2-one derivatives are potent non-competitive metabotropic glutamate receptor 2/3 antagonists, Soc Neurosci Goudet, 2004, Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors, Proc Natl Acad Sci, 101, 378, 10.1073/pnas.0304699101 Grillon, 2003, Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans, Psychopharmacology, 168, 446, 10.1007/s00213-003-1444-8 Hammerland, 1998, Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568, Mol Pharmacol, 53, 1083 Hermans, 1998, Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1a metabotropic glutamate receptor, Neuropharmacology, 37, 1645, 10.1016/S0028-3908(98)00132-4 Higgins, 2004, Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent, Neuropharmacology, 46, 907, 10.1016/j.neuropharm.2004.01.018 Jingami, 2003, Structure of the metabotropic glutamate receptor, Curr Opin Neurobiol, 13, 271, 10.1016/S0959-4388(03)00067-9 Johnson, 2003, Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluroethylsulfonyl)prid-3-ylmethyl-amine, J Med Chem, 46, 3189, 10.1021/jm034015u Kniazeff, 2002, No ligand binding in the GB2 subunit of the GABAB receptor is required for activation and allosteric interaction between the subunits, J Neurosci, 22, 7352, 10.1523/JNEUROSCI.22-17-07352.2002 Knoflach, 2001, Positive allosteric modulators of metabotropic glutamate 1 receptor: characterisation, mechanism of action, and binding site, Proc Natl Acad Sci, 98, 13402, 10.1073/pnas.231358298 Kunishima, 2000, Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor, Nature, 407, 971, 10.1038/35039564 Lavreysen, 2003, [3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists, Mol Pharmacol, 63, 1082, 10.1124/mol.63.5.1082 Levine, 2001, The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by CO2 challenge in patients diagnosed with panic disorder, Neuropharmacology, 43, 294 Litchig, 1999, CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding, Mol Pharmacol, 55, 453 Maj, 2003, (−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection, Neuropharmacology, 45, 895, 10.1016/S0028-3908(03)00271-5 Malherbe, 2001, Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor, Mol Pharmacol, 60, 944, 10.1124/mol.60.5.944 Malherbe, 2003, Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor, J Biol Chem, 278, 8340, 10.1074/jbc.M211759200 Malherbe, 2003, Mutational analysis and molecular modeling of the binding site of the metabotropic glutamate 5 receptor negative modulator 2-Methyl-6-(phenylethynyl)-pyridine, Mol Pharmacol, 64, 823, 10.1124/mol.64.4.823 Marino, 2002, Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics, Curr Drug Target CNS Neurol Disord, 1, 239, 10.2174/1568007023339319 Marino, 2002, Direct and indirect modulation of the N-methyl d-aspartate receptor, Curr Drug Target CNS Neurol Disord, 1, 1, 10.2174/1568007023339544 Marino, 2003, Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment, Proc Natl Acad Sci, 100, 13668, 10.1073/pnas.1835724100 Mathiesen, 2003, Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP, Br J Pharmacol, 138, 1026, 10.1038/sj.bjp.0705159 Nakajima, 1993, Molecular characterisation of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for l-2-amino-4-phosphonobutyrate, J Biol Chem, 268, 11868, 10.1016/S0021-9258(19)50280-0 Nemeth, 1998, Calcimimetics with potent and selective activity on the parathyroid calcium receptor, Proc Natl Acad Sci U S A, 95, 4040, 10.1073/pnas.95.7.4040 Nemeth, 2001, Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone, J Pharmacol Exp Ther, 299, 323 O'Brien, 2003, A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5, Mol Pharmacol, 64, 731, 10.1124/mol.64.3.731 O'Brien, 2004, A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain, J Pharmacol Exp Ther, 309, 568, 10.1124/jpet.103.061747 O'Connor, 1999, Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling, Science, 286, 1180, 10.1126/science.286.5442.1180 O'Hara, 1993, The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins, Neuron, 11, 41, 10.1016/0896-6273(93)90269-W Pagano, 2000, The non-competitive antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors, J Biol Chem, 275, 33750, 10.1074/jbc.M006230200 Parmentier, 2000, Conservation of the ligand recognition site of metabotropic glutamate receptors during evolution, Neuuropharmacology, 39, 1119, 10.1016/S0028-3908(99)00204-X Petrel, 2003, Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca2+-sensing receptor, J Biol Chem, 278, 49487, 10.1074/jbc.M308010200 Pin, 2003, Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors, Pharmacol Ther, 98, 325, 10.1016/S0163-7258(03)00038-X Romano, 1996, Metabotropic glutamate receptor 5 is a disulfide-linked dimer, J Biol Chem, 271, 28612, 10.1074/jbc.271.45.28612 Rosemund, 2002, Molecular determinants of high affinity binding to group III metabotropic glutamate receptors, J Biol Chem, 277, 7333, 10.1074/jbc.M110476200 Sato, 2003, Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1, J Biol Chem, 278, 4314, 10.1074/jbc.M210278200 Schaffhauser, 2003, Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2, Mol Pharmacol, 64, 798, 10.1124/mol.64.4.798 Schoepp, 2002, Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?, Curr Drug Target CNS Neurol Disord, 1, 215, 10.2174/1568007024606177 Schoepp, 1999, Pharmacological agents acting at subtypes of metabotropic glutamate receptors, Neuropharmacology, 38, 1431, 10.1016/S0028-3908(99)00092-1 Schoepp, 2003, LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress, Stress, 6, 189, 10.1080/1025389031000146773 Sheikh, 1996, Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F, Nature, 383, 347, 10.1038/383347a0 Shigemoto, 2000, Metabotropic glutamate receptors-immunocytochemical and in situ hybridisation analysis, vol. 18, 63 Spooren, 2003, Insight into the function of group I and group II metabotropic glutamate (mGlu) receptors: behavioural characterisation and implications for the treatment of CNS disorders, Behav Pharmacol, 14, 257, 10.1097/01.fbp.0000081783.35927.8f Thomas, 2001, (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord, Neurophamacology, 40, 311, 10.1016/S0028-3908(00)00169-6 Tsuchiya, 2002, Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+, Proc Natl Acad Sci U S A, 99, 2660, 10.1073/pnas.052708599 Varney, 2002, Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics, Curr Drug Target CNS Neurol Disord, 1, 283, 10.2174/1568007023339300 Varney, 1999, SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5, J Pharmacol Exp Ther, 290, 170 Walker, 2001, mGlu5 receptors and nociceptive function: II. mGlu5 receptors on peripheral sensory neurones mediate inflammatory hyperalgesia, Neuropharmacology, 40, 10, 10.1016/S0028-3908(00)00114-3 Wichmann, 2002, Alkyl diphenylacetyl, 9H-xanthene- and 9H-thioxanthene-carbonyl carbamates as positive allosteric modulators of mGlu1 receptors, Farmaco, 57, 989, 10.1016/S0014-827X(02)01283-1 Xiao, 2000, Homer: a link between neural activity and glutamate receptor function, Curr Opin Neurobiol, 10, 370, 10.1016/S0959-4388(00)00087-8